FAS and neoplasm: Co-expression of Fas-CD40 displayed greatest tumor killing out of all the Fas-TNFRs, with Fas-CD40-19-BBζ-treated mice having significantly lower tumor burden compared with Fas-41BB-19-BBζ (p = 0.0295) (Figures 6B and 6C).